CD47 and anemia: The local delivery of oAd-mCD47nb-Fc bypasses the neutralizing antibodies present in the circulatory system and increases the intratumoral concentration of the agents, avoiding severe anemia caused by the systemic administration of anti-CD47 monoclonal antibodies.